返回
Alps Group Inc（GLLIR）价格
GLLIR 股价走势图
GLLIR 收益
Alps Group Inc
$0.26
13.04%
$0.03
收盘价：Jan 20, 16:00:00 GMT-5
$0.26
0%
$0
盘后：Jan 20, 20:00:00 GMT-5
关键数据
前收盘价
$0.23
开盘价
$0.221
当日区间
$0.22 - $0.28
52周范围
$0.22 - $0.28
交易量
120.4K
平均成交量
415.6K
每股收益（TTM）
-0.51
股息收益率
--
市值
$43.2M
什么是 GLLIR？
Alps Group Inc is a MY-based company operating in Biotechnology industry. The company is headquartered in Kuala Lumpur, Wilayah Persekutuan. The company went IPO on 2025-10-31. Alps Group Inc is the parent company of Alps Life Sciences Inc., an integrated biotechnology platform integrating research and development, medical services, and wellness solutions of advanced therapies under one unified ecosystem aimed at improving healthcare outcomes globally. The firm has cultivated a diverse pipeline covering various biotechnology research areas. This includes initiatives focused on MyImmune (NK cells), CAR-T cells, COVID-19 mRNA vaccine, diabetes therapeutics, and advancements in stem cell technologies such as induced Pluripotent Stem Cells (iPSCs) and messenger ribonucleic acid (mRNA) platform technology. The firm provides aesthetic treatments, cosmetic procedures, general healthcare and wellness services. The Company’s aesthetic services and cosmetic surgery services include non-surgical aesthetic services and surgical aesthetic services. The company operates a molecular laboratory and a cGMP cell and gene therapy research and cultivation laboratory.